Pfizer's Prevnar, Sanofi-Aventis' ActHIB Vaccines Temporarily Suspended In Japan; Safety Committee Unwilling To Lift Action After First Meeting

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.